| View |
|
DRP-7680-04
|
Sodium Hyaluronate
|
Hyavane
|
1 mg/mL (0.1% w/v)
|
Ophthalmic Solution (Eye Drops)
|
Ocular Lubricant
|
Daewoo Pharm. Co., Ltd
|
Korea
|
Renewal
|
14 June 2024
|
16 December 2029
|
| View |
|
DRP-8078
|
Levofloxacin
|
Voleca
|
500 mg
|
Film-Coated Tablet
|
ANTIBACTERIAL (FLUOROQUINOLONE)
|
PT. Dexa Medica
|
Indonesia
|
Automatic Renewal
|
01 December 2023
|
10 August 2029
|
| View |
|
DRP-8118-02
|
Omeprazole
|
Gastriv
|
40 mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Hizon Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
26 November 2023
|
05 January 2026
|
| View |
|
DRP-8130-01
|
Butamirate Citrate
|
None
|
50 mg
|
Sustained-Release Tablet
|
Cough Suppressant
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
14 December 2023
|
21 March 2029
|
| View |
|
DRP-8204-11
|
Paracetamol + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
|
Triflexa
|
500 mg/ 25 mg/ 2 mg
|
Tablet
|
Analgesic/ Antipyretic/ Nasal Decongestant/ Antihistamine
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
Renewal
|
06 August 2024
|
28 May 2029
|
| View |
|
DRP-8339-04
|
Telmisartan
|
Telbip 40
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
03 December 2023
|
07 May 2029
|
| View |
|
DRP-8352-01
|
Sitagliptin (as phosphate monohydrate)
|
Sitaguard 50
|
50 mg
|
Film-Coated Tablet
|
Antidiabetic Agent (Dipeptidyl peptidase 4 (DPP-4) inhibitor)
|
Theon Pharmaceuticals Limited
|
India
|
Renewal
|
15 June 2024
|
28 August 2029
|
| View |
|
DRP-8374-06
|
Propofol
|
Propocy
|
10 mg/mL (1% w/v)
|
Emulsion for Intravenous Infusion
|
General Anesthetic
|
Guangdong Jiabo Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
04 September 2024
|
17 September 2029
|
| View |
|
DRP-8454-04
|
Telmisartan + Hydrochlorothiazide
|
Telmart Duo
|
40 mg/ 12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker + Diuretic
|
Evertogen Life Sciences Limited
|
India
|
Renewal
|
18 May 2024
|
14 June 2029
|
| View |
|
DRP-8463-01
|
Folic Acid
|
Folibon
|
5 mg
|
Capsule
|
Vitamin
|
San Marino Laboratories Corporation
|
Philippines
|
CLIDP Conversion
|
03 December 2023
|
01 December 2025
|
| View |
|
DRP-8473-03
|
Ceftazidime (as Pentahydrate)
|
CEFDIME
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third Generation Cephalosporin )
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Renewal
|
19 April 2024
|
15 July 2029
|
| View |
|
DRP-8474-01
|
Oxytocin
|
Oxytocy
|
10 I.U./mL
|
Solution for Injection (I.M./I.V.)
|
Oxytocic (Uterine Stimulant)
|
Maanshan BBCA Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
03 December 2023
|
23 April 2025
|
| View |
|
DRP-8493-02
|
Pantoprazole (as sodium sesquihydrate)
|
None
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Bioveeta Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
22 November 2023
|
01 December 2024
|
| View |
|
DRP-8727-03
|
Cetirizine Hydrochloride
|
Cetirilife
|
10 mg
|
Film-Coated Tablet
|
Antihistamine
|
ACME Formulation Pvt. Ltd.
|
India
|
CLIDP Conversion
|
03 December 2023
|
12 February 2025
|
| View |
|
DRP-8727-04
|
Cetirizine Hydrochloride
|
Gotirizine
|
10 mg
|
Film-Coated Tablet
|
Antihistamine
|
ACME Formulations Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 November 2023
|
12 February 2025
|
| View |
|
DRP-8728-04
|
Paracetamol
|
QRACET
|
150 mg/mL
|
Solution for Infusion (IM/IV)
|
Analgesic/ Antipyretic
|
CSPC Ouyi Pharmaceutical Co., Ltd
|
China
|
Renewal
|
24 May 2024
|
30 July 2029
|
| View |
|
DRP-8745-05
|
Cefuroxime (as sodium)
|
Retazet
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
03 December 2023
|
20 February 2025
|
| View |
|
DRP-8765-02
|
Clindamycin (as phosphate)
|
Clinamet
|
150 mg/mL (600 mg/4 mL)
|
Solution for Injection (I.M./I.V.)
|
Antibacterial (Lincosamide)
|
CSPC Ouyi Pharmaceutical Co. Ltd
|
China
|
CLIDP Conversion
|
09 December 2023
|
13 March 2025
|
| View |
|
DRP-884-08
|
Cefuroxime (as Sodium)
|
Medzyme
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Daewon Pharm. Co., Ltd
|
Korea
|
CLIDP Conversion
|
21 November 2023
|
28 September 2027
|
| View |
|
DRP-8845-02
|
Mometasone Furoate
|
Zymocort
|
500 mcg/mL
|
Nasal Spray Suspension
|
Glucocorticoid
|
Hanlim Pharmaceutical Co., Ltd
|
Korea
|
CLIDP Conversion
|
21 November 2023
|
01 December 2025
|